Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Urology and Nephrology

• Publication date

  2015-10-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-015-1136-4PMID 26498629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease

  2016cited by this paper
• Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography

  2014cited by this paper
• Neutrophil gelatinase-associated lipocalin levels associated with cardiovascular disease in chronic kidney disease patients

  2014cited by this paper
• Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Coronary Angiography

  2014cited by this paper
• Prognostic Value of Plasma Neutrophil Gelatinase–Associated Lipocalin for Mortality in Patients With Heart Failure

  2014cited by this paper
• Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.

  2013cited by this paper
• Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness

  2013cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).

  2013cited by this paper
• [Plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts acute kidney injury in septic shock at ICU admission].

  2013cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men.

  2013cited by this paper
• Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness

  2013cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease

  2013cited by this paper
• Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine

  2012cited by this paper
• Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers

  2012cited by this paper
• Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.

  2012cited by this paper
• A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury.

  2012cited by this paper
• CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.

  2012cited by this paper
• Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review

  2012cited by this paper
• Notice

  2012cited by this paper
• The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA *

  2011cited by this paper
• Clinical outcome of renal tubular damage in chronic heart failure.

  2011cited by this paper
• Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

  2011cited by this paper
• Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)

  2011cited by this paper
• Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.

  2011cited by this paper
• Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure.

  2011cited by this paper
• Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.

  2010cited by this paper
• Increased Plasma Neutrophil Gelatinase-Associated Lipocalin Levels Predict Mortality in Elderly Patients with Chronic Heart Failure

  2009cited by this paper
• Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

  2009cited by this paper
• Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Lipocalin-2: Development, Analytical Characterization, and Clinical Testing of a New ELISA

  2008cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury.

  2008cited by this paper
• Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure

  2008cited by this paper
• Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.

  2008cited by this paper
• NGAL in acute kidney injury: from serendipity to utility.

  2008cited by this paper
• Pathological and Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin in Macroproteinuric Patients with Worsening Renal Function

  2008cited by this paper
• NGAL is an early predictive biomarker of contrast-induced nephropathy in children

  2007cited by this paper
• Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study

  2007cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients.

  2007cited by this paper
• Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

  2005cited by this paper
• Lipocalins as biochemical markers of disease.

  2000cited by this paper
• Leukocyte Activation: Relation to Cardiovascular Mortality after Cerebrovascular Ischemia

  2000cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998cited by this paper
• Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

  1994cited by this paper
• Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

  1994cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• Plasma aldosterone regulation in anephric man.

  1973cited by this paper

• Serum neutrophil gelatinase-associated lipocalin and cystatin C is associated with blood pressure in ex-preterm children and adolescents

  2024cites this paper
• Early serum biomarkers of cardiovascular disease in elderly patients with chronic kidney disease.

  2024cites this paper
• Interaction between serum neutrophil gelatinase associated lipocalin and visceral fat area on cardiovascular health in a cohort of community-based individuals.

  2023cites this paper
• The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives

  2023cites this paper
• Serum Neutrophil Gelatinase-associated Lipocalin: A Biomarker of Renal Impairment in Hypertensive Patients

  2021cites this paper
• The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?

  2020cites this paper
• Development and validation of hybrid Brillouin-Raman spectroscopy for non-contact assessment of mechano-chemical properties of urine proteins as biomarkers of kidney diseases

  2020cites this paper
• Sex-specific metabolic functions of adipose Lipocalin-2

  2019cites this paper
• FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis

  2019cites this paper
• Long-Term Outcomes in Patients with Incident Chronic Obstructive Pulmonary Disease after Acute Kidney Injury: A Competing-Risk Analysis of a Nationwide Cohort

  2018cites this paper
• More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases.

  2018influential citation
• Rôle de la Neutrophil Gelatinase-Associated Lipocalin dans les effets cardiovasculaires et rénaux de l'activation du récepteur minéralocorticoïde. Spécificité et mécanismes d’action

  2017cites this paper
• Statistical Methods for Cohort Studies of CKD: Prediction Modeling.

  2017cites this paper
• Serum Lipocalin-2 Predicts Cardiovascular Morbidity Risks in Subclinical Hypothyroid Rat Model = الليبوكالين 2 في مصل الدم يتنبأ بمخاطر اعتلال القلب والأوعية الدموية في نموذج الجرذان المصابة بقصور تحت السريري في الغدة الدرقية

  2016cites this paper